Abstract: The present invention relates to compounds of formula (I): ##STR1## in which A represents the same or different heteroaryl radicals and substituted heteroaryl radicals; B represents dihydroheteroarenediylidene radicals or substituted dihydroheteroarenediylidene radicals or radicals obtainable from these radicals by oxidation on at least one hetero atom; and R' and R" represent the same or different radicals, in particular hydrogen atoms, C.sub.1 - to C.sub.4 -alkyl radicals or radicals A, or cyano radicals, halogen atoms, radicals of the formula --COOR, or --OR, wherein R is a C.sub.1 - to C.sub.4 -alkyl radical, processes for preparing the same and polymers prepared therefrom.

Abstract: A process for preparing an electrically conductive polymer composition which comprises preparing a blend of a solution of an intrinsically conductive polymer and a thermosetting, thermoplastic or elastomeric polymer and removing the solvent, the intrinsically conductive polymer being employed in a weight ratio to the second polymer of from about 0.005:1 to 3:1, the solution having a solids content of from about 2 to 75 weight percent, and the intrinsically conductive polymer being an electrically conductive, stacked macrocyclic metal complex polymer based upon porphyrin or a derivative thereof which comprises an organic bridging ligand containing conjugated pi-electrons allowing delocalization along the polymer chain and in which the metal atom is Fe, R, Rh, Co, Mn or Cr.

Abstract: The present invention provides compounds of the general formula: ##STR1## where R.sub.1 is a hydrogen atom or a methoxy or ethoxy radical and R.sub.2 and R.sub.3 are hydrogen atoms or R.sub.2 and R.sub.3 together represent an aromatic carbon-carbon bond and R.sub.1 is a hydrogen atom, a hydroxyl group or an ethoxy radical; and the pharmaceutically acceptable salts thereof.The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them, as well as their use in therapy.

Abstract: The present invention provides compounds of the general formula: ##STR1## wherein R.sub.1 is a hydrogen atom or a methoxy or ethoxy radical and R.sub.2 and R.sub.3 are hydrogen atoms or R.sub.2 and R.sub.3 together represent an aromatic carbon-carbon bond and R.sub.1 is a hydrogen atom, a hydroxyl group or an ethoxy radical; and the pharmaceutically acceptable salts thereof.The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them, as well as their use in therapy.

Abstract: A perfluoroalkane-sulphinic acid of the formula R.sub.F --SO.sub.2 H is reacted with a diene at -20.degree. to +20.degree. C. to form the new intermediate ##STR1## in which R.sup.3 -R.sup.8 are hydrogen or various organic radicals or double bonds, and that is reacted with a .beta.,.beta.-dimethyl-acrylic acid derivative of the formula ##STR2## in the presence of a base at a temperature between about -20.degree. and +30.degree. C. to produce a cyclopropane carboxylic acid derivative of the formula ##STR3## in which Z is alkoxycarbonyl or cyano and R.sup.1 and R.sup.2 are hydrogen or various organic radicals. The products are known intermediates for insecticides.